Multiple outlets publish highlights and transcripts from Q2 2026 earnings calls for Arcturus Therapeutics and Arcutis (Arcutis Biotherapeutics and Arcturus Therapeutics Holdings). The coverage focuses on management’s discussion of company performance during the quarter and updates tied to ongoing research, development, and operating priorities.
Yahoo Finance presents a summary of Arcturus Therapeutics’ Q2 earnings call highlights, while Seeking Alpha provides fuller context through earnings-call transcripts and, for Arcutis, an accompanying results presentation. Across the articles, the common thread is that executives review financial results for the quarter and comment on business momentum, including progress on product or pipeline efforts. Some sources emphasize condensed “highlights,” while others reproduce more detailed commentary through transcripts and slides.
Because the articles provided are outlet-specific summaries and call materials rather than a single shared news report, the angles differ in depth and format. Yahoo Finance’s piece is designed to be concise, whereas Seeking Alpha’s transcripts and presentations include more detailed statements and structure for investors following each company’s quarter.
